新生儿肺炎应用沐舒坦雾化吸入联合静脉注射治疗的效果观察
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Observation on the Effect of Intramuscular Inhalation Combined with Intravenous Injection of Mucosolvan in Neonatal Pneumonia
  • 作者:解中敏
  • 英文作者:XIE Zhong-min;Yibin Third People's Hospital;
  • 关键词:新生儿肺炎 ; 沐舒坦 ; 雾化吸入 ; 静脉注射 ; 治疗效果
  • 英文关键词:Neonatal pneumonia;;Mucosolvan;;Aerosol inhalation;;Intravenous injection;;Treatment effect
  • 中文刊名:WMIA
  • 英文刊名:World Latest Medicine Information
  • 机构:宜宾市第三人民医院;
  • 出版日期:2019-05-03
  • 出版单位:世界最新医学信息文摘
  • 年:2019
  • 期:v.19
  • 语种:中文;
  • 页:WMIA201936006
  • 页数:2
  • CN:36
  • ISSN:11-9234/R
  • 分类号:18-19
摘要
目的研究新生儿肺炎应用沐舒坦雾化吸入联合静脉注射治疗的效果。方法选择新生儿肺炎患儿作为本次研究对象,并采用"电脑随机法"将100例新生儿肺炎患儿进行分组,主要包括两组,其中观察组实施沐舒坦雾化吸入联合静脉注射治疗;对照组实施沐舒坦静脉注射治疗,分析两组动脉血分压、治疗效果。结果观察组新生儿肺炎患儿PaCO2(41.02±1.23)mmHg低于对照组、PaO2(93.45±2.93)mmHg高于对照组,P<0.05,两组差异具有统计学意义。观察组新生儿肺炎患儿治疗效果较对照组指标更有优势(P<0.05)。结论新生儿肺炎应用沐舒坦雾化吸入联合静脉注射治疗效果显著,且安全性高,能够改善患者各项症状。
        Objective To study the effect of mucosolvan inhalation combined with intravenous injection in neonatal pneumonia.Methods Children with neonatal pneumonia were selected as the study subjects, and 100 children with neonatal pneumonia were divided into two groups by "computer random method", the observation group was treated with mucosolvan aerosol inhalation combined with intravenous injection; the control group was treated with mucosolvan intravenous injection, analysis of arterial blood pressure and treatment effects.Results PaCO2(41.02±1.23) mmHg in the observation group was lower than that in the control group and PaO2(93.45±2.93) mmHg was higher than that in the control group(P<0.05), the difference was statistically significant. The treatment effect of neonatal pneumonia in the observation group was more favorable than the control group(P<0.05).Conclusion Neonatal pneumonia is effective in the treatment of mucosolvan inhalation combined with intravenous injection, and it is safe and can improve the symptoms of patients.
引文
[1]李婕.沐舒坦不同用药途径对新生儿肺炎的白细胞、降钙素原及超敏C反应蛋白的影响分析[J].基因组学与应用生物学,2016,35(5):1081-1087.
    [2]温斌,魏静,李莉娟,等.博利康尼联合沐舒坦雾化吸入治疗对老年慢性阻塞性肺炎新生儿肺炎患儿炎症与免疫功能的影响[J].临床肺科杂志,2016,21(7):1223-1226.
    [3]刘文鹏.沐舒坦雾化吸入联合咳喘贴治疗婴幼儿喘息性支气管炎疗效观察[J].现代中西医结合杂志,2017,26(32):3605-3607.
    [4]陈迎春,李正兰.沐舒坦雾化吸入辅助治疗毛细支气管炎患儿疗效观察[J].海南医学,2017,28(3):488-489.
    [5]杜建波,陆艳蕊,王艳会,等.金振口服液联合雾化吸入硫酸特布他林治疗小儿急性支气管肺炎的疗效观察[J].陕西中医,2016,37(10):1309-1310.
    [6]赵俊荣,王峥,李淑娟,等.地塞米松联合沐舒坦加体位干预治疗新生儿重症吸入性肺炎的疗效观察[J].中国煤炭工业医学杂志,2017,20(4):434-436.
    [7]马娟,王晓蕾,李征瀛,等.肺表面活性物质联合沐舒坦对呼吸窘迫综合征新生儿免疫功能、肝肾功能影响[J].海南医学院学报,2016,22(20):2486-2489.
    [8]叶胜捷,陈如俊,庞淑光,等.早期大剂量乌司他丁联合沭舒坦治疗特重度烧伤对新生儿肺炎患儿呼吸功能及炎性因子的影响[J].中华全科医学,2016,14(1):26-28.
    [9]王振军,谢宗涛,鱼海峰,等.70岁及以上肺癌新生儿肺炎患儿胸腔镜围术期应用氨溴索及异丙托溴铵的疗效[J].中华老年医学杂志,2016,35(6):600-603.
    [10]杨宁,崔轶霞,刘伟.舒利迭联合孟鲁斯特对中重度老年慢性阻塞性肺疾病稳定期效果分析[J].河北医学,2016,22(7):1101-1103.
    [11]吴淑明,郭淑艳,赵旭.肺表面活性物质联合持续气道正压通气治疗新生儿呼吸窘迫综合征的效果研究[J].中国妇幼保健,2017,32(17):4174-4176.
    [12]李鹏程,杨丽娜,史恩红.布地奈德联合盐酸氨溴索雾化吸入治疗新生儿肺炎的临床效果分析[J].世界最新医学信息文摘,2015,15(61):115-116.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700